##gff-version 3
##sequence-region P13500 1 99
P13500	UniProtKB	Signal peptide	1	23	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:2648385;Dbxref=PMID:2648385	
P13500	UniProtKB	Chain	24	99	.	.	.	ID=PRO_0000005146;Note=C-C motif chemokine 2	
P13500	UniProtKB	Site	31	31	.	.	.	Note=Involved in dimerization	
P13500	UniProtKB	Site	36	36	.	.	.	Note=Involved in dimerization%2C receptor binding and signaling	
P13500	UniProtKB	Site	41	41	.	.	.	Note=Involved in GAG binding	
P13500	UniProtKB	Site	42	42	.	.	.	Note=Involved in GAG binding	
P13500	UniProtKB	Site	47	47	.	.	.	Note=Involved in GAG binding and receptor binding	
P13500	UniProtKB	Site	58	58	.	.	.	Note=Involved in dimerization	
P13500	UniProtKB	Site	61	61	.	.	.	Note=Involved in dimerization	
P13500	UniProtKB	Site	72	72	.	.	.	Note=Involved in GAG binding and receptor binding	
P13500	UniProtKB	Site	81	81	.	.	.	Note=Involved in GAG binding	
P13500	UniProtKB	Site	89	89	.	.	.	Note=Involved in GAG binding	
P13500	UniProtKB	Modified residue	24	24	.	.	.	Note=Pyrrolidone carboxylic acid;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:1661560,ECO:0000269|PubMed:2648385;Dbxref=PMID:1661560,PMID:2648385	
P13500	UniProtKB	Glycosylation	37	37	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P13500	UniProtKB	Disulfide bond	34	59	.	.	.	.	
P13500	UniProtKB	Disulfide bond	35	75	.	.	.	.	
P13500	UniProtKB	Mutagenesis	24	91	.	.	.	Note=83%25 reduction in activity. Missing	
P13500	UniProtKB	Mutagenesis	24	85	.	.	.	Note=90%25 reduction in activity. Missing	
P13500	UniProtKB	Mutagenesis	24	24	.	.	.	Note=Loss of activity. Missing	
P13500	UniProtKB	Mutagenesis	25	31	.	.	.	Note=Loss of signaling. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10587439;Dbxref=PMID:10587439	
P13500	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Reduction in activity. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10587439;Dbxref=PMID:10587439	
P13500	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Slight reduction in activity. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10587439;Dbxref=PMID:10587439	
P13500	UniProtKB	Mutagenesis	29	29	.	.	.	Note=50%25 reduction in activity. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10587439;Dbxref=PMID:10587439	
P13500	UniProtKB	Mutagenesis	31	31	.	.	.	Note=Loss of dimerization%3B slight reduction of activity. P->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587439,ECO:0000269|PubMed:9837883;Dbxref=PMID:10587439,PMID:9837883	
P13500	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Slight reduction in activity. V->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587439,ECO:0000269|PubMed:9837883;Dbxref=PMID:10587439,PMID:9837883	
P13500	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Slight reduction in affinity. V->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587439,ECO:0000269|PubMed:9837883;Dbxref=PMID:10587439,PMID:9837883	
P13500	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Slight reduction in activity. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587439,ECO:0000269|PubMed:9837883;Dbxref=PMID:10587439,PMID:9837883	
P13500	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Slight reduction in affinity. T->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10587439,ECO:0000269|PubMed:9837883;Dbxref=PMID:10587439,PMID:9837883	
P13500	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Loss of activity. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9837883;Dbxref=PMID:9837883	
P13500	UniProtKB	Mutagenesis	47	47	.	.	.	Note=95%25 reduction in activity%3B strong reduction of receptor binding. R->F	
P13500	UniProtKB	Mutagenesis	50	50	.	.	.	Note=40%25 reduction in activity. S->Q	
P13500	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Loss of activity. Y->D	
P13500	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Loss of activity. R->L	
P13500	UniProtKB	Mutagenesis	79	79	.	.	.	Note=No effect on heparin binding. K->A	
P13500	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Strongly reduces heparin binding. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9792674;Dbxref=PMID:9792674	
P13500	UniProtKB	Mutagenesis	89	89	.	.	.	Note=Strongly reduces heparin binding. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9792674;Dbxref=PMID:9792674	
P13500	UniProtKB	Mutagenesis	91	91	.	.	.	Note=90%25 reduction in activity. D->L	
P13500	UniProtKB	Mutagenesis	95	99	.	.	.	Note=No effect on heparin binding. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9792674;Dbxref=PMID:9792674	
P13500	UniProtKB	Helix	25	29	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	32	34	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Helix	45	47	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	48	54	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	59	61	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	63	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	73	76	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	78	80	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZK9	
P13500	UniProtKB	Helix	81	92	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DOK	
P13500	UniProtKB	Beta strand	93	95	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1DON	
